These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 190189)
1. [ACTH therapy of dermatoses]. Schuppli R Hautarzt; 1977 Jan; 28(1):1-4. PubMed ID: 190189 [No Abstract] [Full Text] [Related]
2. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences]. Harnack K; Flegel P Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833 [No Abstract] [Full Text] [Related]
8. [Discussion of a case of dyschromia]. Nicolay M; Piot V Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809 [No Abstract] [Full Text] [Related]
9. [Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma]. Rott Z; Fajt E; Tóth S; Hammer I; Nagy G Orv Hetil; 1983 Jul; 124(31):1883-6. PubMed ID: 6314223 [No Abstract] [Full Text] [Related]
10. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema. Munro DD Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340 [TBL] [Abstract][Full Text] [Related]
11. [Tetracosactide in the treatment of rheumatoid arthritis and gout]. Usobiaga JL Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406 [No Abstract] [Full Text] [Related]
12. [Combined ACTH and cortisone therapy in impetigo herpetiformis in a man, mycosis fungoides and erythroderma psoriatica]. ESSEN LE Sven Lakartidn; 1951 Aug; 48(35):2013-35. PubMed ID: 14884116 [No Abstract] [Full Text] [Related]
13. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity. Glass D; Roffe L; Maini RN; Wraith DG; Nuki G Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487 [TBL] [Abstract][Full Text] [Related]
14. [Synacthene-Retard in mental confusion of aged patients]. Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577 [No Abstract] [Full Text] [Related]
15. [Indications and limitations of the use of ACTH in clinical practice]. Molinatti G; Massara F Clin Ter; 1978 Feb; 84(4):353-60. PubMed ID: 206403 [No Abstract] [Full Text] [Related]
16. [Hematological side-effects in the treatment of dermatoses with ACTH & cortisone]. FOELSCHE W; KRUG K Z Gesamte Inn Med; 1958 Dec; 13(24):1016-22. PubMed ID: 13648544 [No Abstract] [Full Text] [Related]
17. [Stimulation of the adrenal cortex in long-term steroid therapy. Increase of free cortisol in the urine following depot ACTH administration]. Nolte D; Gallenberger S; Borgolte H; Vecsei P; Haack D Fortschr Med; 1986 Jun; 104(22):444-7. PubMed ID: 3017824 [No Abstract] [Full Text] [Related]
18. West's syndrome and its treatment. Sorel L Clin Electroencephalogr; 1985 Jul; 16(3):122-7. PubMed ID: 2994911 [No Abstract] [Full Text] [Related]
19. [Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood]. John K; Gaida P; Kauf E Padiatr Grenzgeb; 1985; 24(5):391-9. PubMed ID: 2999679 [No Abstract] [Full Text] [Related]
20. Pituitary adrenocorticotropic hormone (ACTH) and cortisone in diseases of the skin. I. Pemphigus vulgaris and other bullous dermatoses. CANNON AB; HOPKINS JG; ANDREWS GC; COLFER HF; GROSS P; NELSON CT; HOWELL CM J Am Med Assoc; 1951 Jan; 145(4):201-6. PubMed ID: 14794422 [No Abstract] [Full Text] [Related] [Next] [New Search]